featured
Efficacy of Treatment With Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis Through 76 Weeks
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis: Analysis of 3 Phase 3 Randomized Clinical Trials Through 76 Weeks
JAMA Dermatol 2024 Oct 23;[EPub Ahead of Print], AS Paller, P Mendes-Bastos, E Siegfried, LF Eichenfield, W Soong, VH Prajapati, P Lio, EL Simpson, EM Raymundo, S Suravaram, X Hu, Y Yang, X Huang, BM Calimlim, AM Platt, JC Su, M Zheng, K Yamamoto-Hanada, HD Teixeira, AD IrvineFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.